X0609 4 2026-10-20 0001175680 CytoDyn Inc. CYDY 0001166288 Hoffman Robert E. false 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 false true false false Chief Executive Officer false Non-qualified stock option (right to buy) 0.25 2026-10-20 4 A false 2500000 0 A 2036-10-16 Common Stock 2500000 2500000 D This grant was approved by the Company's Compensation Committee on October 16, 2026, pursuant to the Issuer's 2012 Equity Incentive Plan (the "Plan"). 625,000 shares will vest on October 16, 2027, and the balance will vest in equal monthly installments beginning on November 16, 2027 and ending on October 16, 2030, subject to Continuous Service (as the term is defined in the Plan). /s/ Tyler Blok, attorney-in-fact for Robert E. Hoffman 2026-10-20